Target Details
| UniProt AC | P05129 |
|---|---|
| Gene Symbol | PRKCG |
| Protein Name | Protein kinase C gamma type |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00130 (C1_1) PF00168 (C2) PF00069 (Pkinase) PF00433 (Pkinase_C) |
Summary
- Multi-target molecules 311
- Clinical molecules 119
- Avg pChEMBL 7.06
KEGG Pathways (64)
- African trypanosomiasis
- Aldosterone synthesis and secretion
- Aldosterone-regulated sodium reabsorption
- Amoebiasis
- Amphetamine addiction
- Calcium signaling pathway
- Chemical carcinogenesis - receptor activation
- Choline metabolism in cancer
- Cholinergic synapse
- Circadian entrainment
- Coronavirus disease - COVID-19
- Diabetic cardiomyopathy
- Dopaminergic synapse
- EGFR tyrosine kinase inhibitor resistance
- Endocrine and other factor-regulated calcium reabsorption
- ErbB signaling pathway
- Fc gamma R-mediated phagocytosis
- Focal adhesion
- GABAergic synapse
- Gap junction
- Gastric acid secretion
- Glioma
- Glutamatergic synapse
- GnRH secretion
- Growth hormone synthesis, secretion and action
- HIF-1 signaling pathway
- Hepatitis B
- Hepatocellular carcinoma
- Human cytomegalovirus infection
- Human immunodeficiency virus 1 infection
- IgSF CAM signaling
- Inflammatory mediator regulation of TRP channels
- Insulin secretion
- Leukocyte transendothelial migration
- Long-term depression
- Long-term potentiation
- MAPK signaling pathway
- Melanogenesis
- MicroRNAs in cancer
- Morphine addiction
- Natural killer cell mediated cytotoxicity
- Neuroactive ligand signaling
- Neutrophil extracellular trap formation
- Non-small cell lung cancer
- Oxytocin signaling pathway
- Pancreatic secretion
- Parathyroid hormone synthesis, secretion and action
- Pathways in cancer
- Pathways of neurodegeneration - multiple diseases
- Phosphatidylinositol signaling system
- Proteoglycans in cancer
- Rap1 signaling pathway
- Ras signaling pathway
- Retrograde endocannabinoid signaling
- Salivary secretion
- Serotonergic synapse
- Sphingolipid signaling pathway
- Spinocerebellar ataxia
- Thyroid hormone signaling pathway
- Thyroid hormone synthesis
- VEGF signaling pathway
- Vascular smooth muscle contraction
- Wnt signaling pathway
- mTOR signaling pathway
Associated Diseases (1)
Active Molecules (311)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
PQWWKDOKHDWZBH
|
6.3 | IC50 | 6 | — | |
CPRVBHBRBVVLHL
|
6.3 | IC50 | 11 | — | |
ATBAETXFFCOZOY
|
6.3 | IC50 | 39 | — | |
CCRCRSXDKXZDGK
|
6.3 | IC50 | 12 | Yes | |
DPRGOXVMSNDADU
|
6.3 | Ki | 16 | — | |
HCJOTKSJPHFVJC
|
6.3 | IC50 | 6 | — | |
HOBMVEVXDIOMDM
|
6.3 | Ki | 18 | — | |
JQGRMZUVGWRDIV
|
6.3 | IC50 | 6 | — | |
MASJMHFQMYAPJR
|
6.3 | Ki | 41 | — | |
VGNKOJURPOHWJF
|
6.3 | Ki | 21 | — | |
ZWVZORIKUNOTCS
|
6.3 | Ki | 69 | — | |
AOIKKLIBKSSHQP
|
6.3 | IC50 | 4 | — | |
JSPAUBUYPPZXSG
|
6.3 | Ki | 17 | Yes | |
ORNADCNXUPZOQN
|
6.3 | IC50 | 15 | — | |
KLSYPIQWMFSSJW
|
6.3 | IC50 | 8 | — | |
RZHAEOSLBJVDFX
|
6.3 | IC50 | 5 | — | |
NEGCBIBMPAHBIM
|
6.3 | IC50 | 12 | Yes | |
BAQFZMFDZMQJAM
|
6.2 | IC50 | 12 | Yes | |
TXBFOGDMTCNBBT
|
6.2 | IC50 | 12 | Yes | |
QQKKPWJFHBFCTH
|
6.2 | IC50 | 10 | Yes | |
TWUWFRLZDWDJLT
|
6.2 | Ki | 10 | Yes | |
ZUKHVOLIPVGCHQ
|
6.2 | Ki | 10 | Yes | |
CLRFYTGANQZOBS
|
6.2 | Ki | 41 | — | |
HAYYBYPASCDWEQ
|
6.2 | Ki | 47 | — | |
HLXIFVDYTGEUJV
|
6.2 | IC50 | 15 | Yes | |
USHMNZBDAOGLMB
|
6.2 | Ki | 26 | — | |
KPJDEGAKXAUVAC
|
6.2 | Ki | 15 | Yes | |
MVQGUYKZTHVOEH
|
6.2 | Ki | 8 | Yes | |
CWFIQHQECWPWQG
|
6.2 | IC50 | 16 | Yes | |
ORNADCNXUPZOQN
|
6.2 | IC50 | 15 | — | |
DVXSJBDRMIDVMC
|
6.2 | IC50 | 3 | — | |
HXWARSZQGAFXJM
|
6.1 | Ki | 7 | — | |
AXTAPYRUEKNRBA
|
6.1 | IC50 | 24 | — | |
AOBLBPWPSKBHSI
|
6.1 | Ki | 55 | — | |
KXPWWMPXNUOYOH
|
6.1 | Ki | 24 | — | |
RYYNGWLOYLRZLK
|
6.1 | Ki | 104 | — | |
SHENEEFOURUIBP
|
6.1 | Ki | 29 | — | |
WSXYBDKZFNJOTP
|
6.1 | IC50 | 12 | Yes | |
YPJJSXBVVGPFHA
|
6.1 | Ki | 18 | — | |
ZRTWUBWXIGHVET
|
6.1 | Ki | 10 | — | |
MRBNLCLXWRXFJX
|
6.1 | IC50 | 15 | — | |
DWKWEQIKOVHMQW
|
6.1 | IC50 | 3 | — | |
GHRBXKFGXPOEGA
|
6.0 | IC50 | 12 | Yes | |
OYPYXQXNEBSSGB
|
6.0 | Ki | 8 | Yes | |
QUTRBEMNJLJANB
|
6.0 | IC50 | 4 | — | |
CLEGDJQQHUTCOW
|
6.0 | Ki | 43 | — | |
FNTXTLNLTQPVBJ
|
6.0 | IC50 | 6 | — | |
FYHDYXSOJZTOJN
|
6.0 | IC50 | 3 | — | |
FYHDYXSOJZTOJN
|
6.0 | IC50 | 4 | — | |
IVVSBEQDCAZLFY
|
6.0 | IC50 | 333 | — |